About The Column Group
The Column Group is a venture capital firm dedicated to creating the next generation of biotechnology companies. They manage over $4 billion in assets and focus on building companies with groundbreaking scientific platforms that have the potential to deliver significant new therapies for unmet medical needs. TCG takes a long-term approach, aiming to develop companies capable of generating multiple product opportunities rather than focusing on quick exits.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Biotechnology, AI/ML, Healthcare (+2 more)
Investor Type
Venture Capital
Investment Focus
Focus Areas
Investment Stages